More than 37,000 Americans will be diagnosed this year with pancreatic cancer. Around 75 percent of those diagnosed will die of their disease. Pancreatic cancer is the fourth leading cause of cancer deaths in the United States, yet one of the most underfunded for research.
Only one percent of the National Cancer Institute research investment money was spend on pancreatic cancer in 2006. The Pancreatic Cancer Action Network (PanCAN) are calling on Congress to support a minimum of 6.7 percent increase to meet this urgent need.
Julie Fleshman, PanCAN President and CEO, says "The need for more research is tremendous and our voices must be heard. No effective early detection methods currently exist and there are minimal treatment options available. And very little research being done due to limited research funding".
The Pancreatic Cancer Action Network established in 1999, is the first national patient advocacy organization for the pancreatic community. PanCAN works to focus national attention on the need to find a cure for pancreatic cancer. They provide public and professional education embracing the urgent need for more research, effective treatments, prevention programs and early detection methods.
